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Abstract
Multipotent mesenchymal stromal cells (MSC) are currently investigated clinically as cellular therapy for a variety of diseases.
Differentiation of MSC toward endodermal lineages, including hepatocytes and their therapeutic effect on fibrosis has been
described but remains controversial. Recent evidence attributed a fibrotic potential to MSC. As differentiation potential might
be dependent of donor age, we studied MSC derived from adult and pediatric human bone marrow and their potential to
differentiate into hepatocytes or myofibroblasts in vitro and in vivo. Following characterization, expanded adult and pediatric
MSC were co-cultured with a human hepatoma cell line, Huh-7, in a hepatogenic differentiation medium containing
Hepatocyte growth factor, Fibroblast growth factor 4 and oncostatin M. In vivo, MSC were transplanted into spleen or liver of
NOD/SCID mice undergoing partial hepatectomy and retrorsine treatment. Expression of mesenchymal and hepatic markers
was analyzed by RT-PCR, Western blot and immunohistochemistry. In vitro, adult and pediatric MSC expressed characteristic
surface antigens of MSC. Expansion capacity of pediatric MSC was significantly higher when compared to adult MSC. In co-
culture with Huh-7cells in hepatogenic differentiation medium, albumin expression was more frequently detected in pediatric
MSC (5/8 experiments) when compared to adult MSC (2/10 experiments). However, in such condition pediatric MSC expressed
alpha smooth muscle more strongly than adult MSC. Stable engraftment in the liver was not achieved after intrasplenic
injection of pediatric or adult MSC. After intrahepaticinjection,MSCpermanently remained in liver tissue, kept a mesenchymal
morphology and expressed vimentin and alpha smooth muscle actin, but no hepatic markers. Further, MSC localization
merges with collagen deposition in transplanted liver and no difference was observed using adult or pediatric MSC. In
conclusion, when transplanted into an injured or regenerating liver, MSC differentiated into myofibroblasts with development
of fibrous tissue, regardless of donor age. These results indicate that MSC in certain circumstances might be harmful due to
their fibrogenic potential and this should be considered before potential use of MSC for cell therapy.
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Introduction
Currently, orthotopic liver transplantation is the only treatment
for fulminant and end-stage liver diseases. As patients die on
transplant waiting lists due to insufficient numbers of organ
donors, alternative therapies need urgently to be developed. Adult
and embryonic stem cells are potential options to overcome the
lack of organ availability. Studies have shown that bone marrow
cells migrate and integrate into the liver suggesting that the bone
marrow contains hepatocyte progenitor cells [1–3]. One potential
candidate is the multipotent mesenchymal stromal cells (MSC).
These cells present criteria of a transplantable stem cell, especially
for the use of autologous cell transplantation, as MSC are easily
accessible and present high expansion potential in vitro.
MSC have been identified in the bone marrow [4] and in
various human tissues [5,6]. MSC are able to differentiate into
chondrocytes, adipocytes and osteoblasts [4,7]. Several studies
indicate that MSC might have the ability to cross cell lineage
boundaries and differentiate towards or into hepatocytes in vitro.A
two-step protocol, using hepatocyte growth factor (HGF) and
oncostatin M induced hepatocyte specific gene expression in clonal
expanded MSC derived from bone marrow and human cord-
blood [8]. Further, co-culturing rat MSC with isolated rat liver
cells in medium containing several growth factors induced
expression of hepatocyte-specific genes [9].
However, therapeutic potential of MSC for supporting liver
regeneration is not clear. MSC transplantation into rodents with
carbon tetrachloride (CCl4) -induced liver injury resulted in
reduced liver fibrosis [10,11]. In contrast, others showed that
reduction of fibrosis was not influenced by transplantation of MSC
[12]. In some mouse models of liver injury, using either partial
hepatectomy or injection of toxic agents such as CCl4 or
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expression was detected [13,14].
Further investigations are required to determine if MSC
represent a therapeutic option for liver disease. Importance of
donor age of MSC on engraftment and differentiation into
hepatocytes has not been evaluated. Age is critical for chromo-
somal stability [15], telomerase activity [16,17] and thus
differentiation potential. In this study, we investigated the potential
of MSC derived from human adult (aMSC) and pediatric bone
marrow (pMSC) to differentiate into hepatocytes. When co-
cultured with Huh-7 cells, a human hepatoma cell line, in medium
containing endodermal growth factors, pMSC expressed albumin
more frequently compared to aMSC. Independently of age, MSC
transplanted into liver did not differentiate into hepatocytes but
remained mesenchymal and expressed collagen and alpha smooth
muscle actin (aSMA), a marker for myofibroblast differentiation.
These results show that MSC exposed to an injured liver
environment in mice can contribute to a fibrogenic tissue. As
MSC are currently tested clinically to treat bone diseases [18,19]
or graft versus host disease [20], it is important to assess a potential
harmful effect on liver tissue.
Results
Characterization of adult and pediatric bone marrow-
derived multipotent mesenchymal stromal cells
We isolated MSC from 38 adult donors (mean age: 59612
years) and 11 pediatric donors (mean age: 1063 years). Adult
MSC were expanded for 563 passages to 19 population doublings
(PD), whereas pediatric MSC (pMSC) were expanded for 864
passages to 24 PD. The difference of passage numbers and
expansion potential between the 2 groups were statistically
significant (p=0.016 and p=0.00006, respectively). Adult MSC
and pMSC showed a similar fibroblast-like morphology (Fig. 1A).
Expanded cells were characterized by FACS analysis and were
negative for HLA class1, CD34 and CD45, but were positive for
CD44, CD54, CD90 and CD105 (Fig. 1B). CD36 was not
expressed in pMSC whereas a double population was observed in
aMSC. The expression level of CD106 varied between donors (not
shown). This expression pattern remained unchanged from
passages 3 to 7. CD31 and CD133 were negative in both
populations (data not shown).
Adipogenic, chondrogenic and osteogenic
differentiation of adult and pediatric MSC
Adult MSC and pMSC could be differentiated into adipocytes
as shown by oil-red-O staining of lipid droplets (Fig. 1C), into
chondrocytes as shown by Masson’s trichrome and immunohis-
tochemistry for collagen type II (Fig. 1D) and into osteoblasts
expressing alkaline phosphatase activity (Fig. 1E). For all
mesodermal differentiation experiments, no difference was ob-
served between aMSC and pMSC.
Adult and pediatric MSC do not exhibit different
telomerase activity
Telomerase activity of MSC in culture remains controversial
[16,17,21]. We analyzed telomerase activity of aMSC and pMSC
in order to determine whether differences in expansion capacities
could be related to different activity of telomerase (Fig. 2).
Telomerase activity of MSC was measured and normalized to a
positive control provided by the assay. IHH, cells transduced with
lentivectors coding for telomerase, were used as a positive control
for quality of cell extracts. These cells displayed almost fourteen
times more telomerase activity than the provided positive control.
As shown in figure 2, telomerase activity in MSC extracts was low
compared to positive control and not significantly different
between aMSC and pMSC (p.0.4).
Pediatric MSC co-cultured with Huh-7 cells express more
frequently albumin and alpha 1 anti-trypsin compared to
adult MSC
In order to induce hepatocyte differentiation, we cultured
aMSC and pMSC at high density on Matrigel coated wells for
24 h and added hepatogenic differentiation medium as previously
described [22] containing HGF, fibroblast growth factor 4 (FGF4)
and oncostatin M, for 4 weeks. This medium failed to induce alpha
fetoprotein (aFP) or albumin expression in both aMSC (Fig. 3A)
and pMSC (data not shown). We then co-cultured aMSC or
pMSC with Huh-7 cells in hepatogenic differentiation medium in
a transwell system preventing direct cell-cell contacts between
different cell types. In these conditions, aMSC expressed albumin
and alpha 1 anti-trypsin (API) in 2 of 10 independent experiments,
and this exclusively in conditions in which hepatogenic differen-
tiation medium were present (Fig. 3B). However, aMSC
expressing albumin did not express aFP. By applying identical
conditions to pMSC, we observed albumin and API expression in
5 out of 8 independent experiments. Here, in 2 out 5 positive
experiments, addition of hepatogenic differentiation medium was
not necessary and co-culture with Huh-7 cells was sufficient to
induce albumin expression (Fig. 3C). Epithelial markers for
hepatoblasts, hepatocytes and cholangiocytes, like cytokeratin 18
(CK18) and cytokeratin 19 (CK19), were expressed in all
conditions, in presence or absence of growth factors (data not
shown). However, we did not detect albumin at the protein level
(data not shown).
Alpha smooth muscle actin is present in MSC cultured in
hepatogenic differentiation medium and in Huh-7 cells
conditioned medium
A recent study indicated that bone marrow cells contribute
significantly to hepatic stellate cells and myofibroblasts differen-
tiation in a murine model of liver cirrhosis [23]. We therefore
analyzed whether MSC express genes specific to myofibroblasts
when cultured in hepatogenic differentiation medium alone or co-
cultured with Huh-7 cells in hepatogenic differentiation medium
for four weeks. aSMA was expressed strongly in pMSC and to a
lesser extent in aMSC when cultured in hepatogenic differentia-
tion medium as well as co-cultured with Huh-7 cells in
hepatogenic differentiation medium (Fig. 4A). Adult MSC also
express aSMA in control media containing low percentages of
FCS to avoid overgrowing during the 4 weeks of culture (Fig. 4A).
We then compared aMSC and pMSC with foreskin fibroblasts
(EDX) for their ability to express aSMA (Fig. 4B). After culture in
Huh-7 cells conditioned medium we observed an up-regulation of
aSMA in aMSC and pMSC already at 10 d (Fig. 4B). This was
not observed in EDX cells.
After intrahepatic injection, adult MSC and pediatric MSC
engraft but do not differentiate into hepatocytes
To investigate the engraftment capacity of aMSC and pMSC
and their ability to participate in liver regeneration, we injected 0.5
to 1610
6 untreated aMSC and pMSC directly into the spleen after
30% or 70% hepatectomy of non-obese-diabetic/severe combined
immunodeficient (NOD/SCID) mice (Table 1). By immunofluo-
rescence staining on spleen sections, using an antibody recognizing
exclusively human vimentin and not mouse vimentin as verified by
Human MSC in Injured Liver
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demonstrated that aMSC and pMSC survived in the spleen up to
8 weeks after transplantation (Fig. 5A). Cells expressing vimentin
remained fibroblast-like. During the first week after intrasplenic
injection, few MSC were detected within the liver (Fig. 5A).
In order to analyze effects of liver parenchyma on MSC, we
injected aMSC and pMSC directly into liver parenchyma.
Immunohistochemistry studies showed that pMSC were still
present after 8 weeks (Fig. 5B). Extend of engraftment varied
from a restricted localization near the border of the liver capsule to
a diffuse engraftment in the whole liver lobe where cell injection
had been performed (see Table 1: Summary of in vivo
experiments). Using an anti-human albumin Ab, we analyzed
liver sections at 3 levels. We did not detect human albumin within
the liver at any stage after transplantation (Fig. 6A). In accordance
to this, RT-PCR on liver samples showed that neither CK18,
cytochrome P450 (CYP3A4) (data not shown), aFP, nor albumin
but vimentin was expressed, demonstrating that MSC are present
but differentiation into hepatocytes did not occur (Fig. 6B). The
outcome was identical when hepatectomy was preceded by
retrorsine treatment, a treatment blocking endogenous hepatocyte
proliferation [24].
Engrafted MSC in liver express alpha smooth muscle
actin and their localization merges with collagen
deposition
During fibrosis, myofibroblasts expressing aSMA appear within
the liver. Recently, it has been shown that these cells can be of
bone marrow origin [25]. Therefore we investigated whether
transplanted MSC could differentiate in myofibroblasts. Staining
for aSMA on sections of transplanted mouse liver showed that
MSC express aSMA (Fig. 7A). Antibody against aSMA is not
human specific and stains smooth muscle cells around blood
vessels of mouse livers as shown on liver sections of sham injected
mice (Fig. 7B, b and d). Histochemistry using Masson’s trichrome
on serial sections showed that collagen deposition merges with
vimentin- and aSMA-expressing MSC (Fig. 7A, a, b and f).
Discussion
MSC are currently tested clinically to treat various bone diseases
[26,27] or graft versus host disease [20]. MSC are also investigated
experimentally as cell-based therapies for liver failure. As age might
influence plasticity of MSC, we investigated the potential of aMSC
and pMSC to engraft and participate in liver regeneration. We first
Figure 1. Characterization of adult and pediatric multipotent mesenchymal stromal cells. A) Fibroblast-like morphology of adult (a) and
pediatric (b) MSC. Both cell types showed similar morphology. B) Flow cytometry of cells stained for CD34, CD36, CD44, CD45, CD54, CD90, CD105,
CD106, HLA ABC and isotype controls showing similar expression of surface antigens in adult (a) and pediatric (b) MSC. A representative example of
adult and pediatric MSC is shown. Red histograms: specific marker; unfilled black histograms: isotype controls. C) Adipogenic differentiation was
induced with adipocyte differentiation medium. After 3 weeks aMSC (a) and pMSC (b) were fixed and stained with Oil-red-O. In control medium
(Insets), very few cells contained lipid droplets. In adipogenic differentiation medium a majority of cells contained lipid droplets stained in red. D)
Chondrogenic differentiation was induced in MSC pellet culture in chondrogenic differentiation medium. After 4 weeks, pellets were fixed and
sections were analyzed using Masson trichrome staining (a,b blue) and anti-collagen type II immunohistochemistry (c,d red). The images represent
zoomed portion (delimitated by white frames) of the picture shown in the insets. The pellet structure appeared compact and contained abundant
collagen fibrils. E) Osteogenic differentiation was induced by culturing aMSC (a) and pMSC (b) in osteogenic differentiation medium. After 4 weeks,
cells were washed and incubated with Fast red and Sodium alpha-naphtyl phosphate solutions for 30 min at 4uC. Nuclei were stained with hemalun.
MSC expressing alkaline phosphatase showed brown colored cytoplasm and displayed typical star-shaped cell morphology. In control medium
(Insets), only few cells showed alkaline phosphatase expression.
doi:10.1371/journal.pone.0006657.g001
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up to 18 and 24 PD, respectively. We confirmed previous reports
showing that pMSC achieved higher PD and that both cell types
reach senescence [28]. This difference in proliferation could not be
explained by a difference in telomerase activity. This is in
accordance with two recent publications, analyzing proliferation
and telomerase activity in MSC [16,17]. Age-related reduction of
colony-forming units as well as increased levels of molecules
implicated in cellular aging such as reactive oxygen species and
nitric oxide have been observed in MSC [29] and might influence
their proliferation capacity.
Qualitative analysis demonstrated that differentiation into
adipocytes, osteoblasts and chondrocytes was possible for both
MSC populations. Among surface antigens tested, pMSC and
aMSC differed solely for expression of CD36. CD36, a scavenger
receptor class B1 [30] was not expressed by pMSC. Recent studies
showed that CD36 mediates cellular uptake of long chain fatty
acids and their intestinal absorption in mice [31]. As both aMSC
and pMSC differentiate into adipocytes, CD36 seems not to be
important for the in vitro differentiation of MSC into adipocytes.
The importance of this receptor in MSC biology has not been
investigated so far.
In our experiments, induction of hepatocyte-specific genes in
MSC failed by using previously reported culture conditions
[14,8,22]. In contrast, co-culture with Huh-7 cells induced
albumin expression in aMSC and pMSC. Pediatric MSC
Figure 2. Telomerase activity in adult and pediatric MSC.
Telomerase activity of adult and pediatric MSC from 4 different donors
and at different passages (1 to 4) was measured and normalized to a
provided positive control set as 100 percent. Immortalized human
hepatocytes (IHH) were used as quality controls of cell extracts
containing telomerase; IHH are immortalized cells transduced with
lentivectors coding for telomerase [44]. As compared to control,
telomerase activity was low and not significantly different between
aMSC and pMSC (p.0.4).
doi:10.1371/journal.pone.0006657.g002
Figure 3. Induction of hepatocyte specific genes in adult and pediatric MSC after co-culture with Huh-7 cells. A) aMSC were cultured
for 4 weeks in hepatogenic differentiation medium containing HGF, FGF4 and Oncostatin M. RT-PCR analysis of aFP and albumin expression shows no
induction of hepatocyte specific gene expression. C-, negative control, PCR without polymerase. Huh-7, positive control for aFP and albumin
expression. Lane 3, 4, 5 and 6: aMSC from different donors. B) Adult MSC were co-cultured with Huh-7 cells in a transwell system, with or without
hepatogenic differentiation medium (Diff. Media+/2). C-, negative control. RT-PCR analysis was done on total RNA extracts from aMSC co-cultured
with Huh-7 cells for aFP, albumin and API. Huh-7 cells from transwell of same experience were used as a positive control for aFP and albumin. In 2 of
10 independent experiments, we observed in MSC co-cultured with Huh-7 cells in hepatogenic differentiation medium. The result represents one of
the two positives results obtained. C) PMSC were co-cultured under same conditions as aMSC. C-, negative control. In 5 of 8 independent
experiments, we observed aFP, albumin and API expression in MSC, independently of the presence of hepatogenic differentiation medium. The result
represents one of the 5 positives results obtained. API: alpha1 anti-trypsin; aFP: alpha fetoprotein; Huh-7: human hepatoma cell line.
doi:10.1371/journal.pone.0006657.g003
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culture with Huh-7 cells without hepatogenic differentiation
medium was sufficient to induce albumin expression. Contamina-
tion of underlying MSC with Huh-7 cells from the upper
compartment (transwell) was excluded by performing experiments
in an inverted cell-setting. We suggest that soluble factors secreted
by Huh-7 cells are responsible for induction of hepatogenic gene
expression. However, the fact that we did not detect albumin at
protein levels suggest that there might only be a small population
of MSC differentiating towards hepatocytes.
Other studies using subpopulations isolated from MSC obtained
from pediatric donors demonstrated that expression of hepatic
genes can be induced [22]. Hepatocyte differentiation was
observed in vitro in MSC derived from umbilical cord blood [32]
or umbilical cord matrix [14]. Campard and colleagues reported
that a small proportion of umbilical cord-derived MSC expressed
albumin, as shown by flow cytometry. Hepatocyte differentiation
has also been observed in human adipose-tissue derived-MSC
[33]. There is growing evidence that MSC exhibit potential to
express hepatogenic lineage markers but development of signifi-
cant amounts of functional hepatocytes has still to be achieved.
When cultured in hepatogenic differentiation medium alone or
co-cultured with Huh-7 cells in differentiation medium, aMSC
and more importantly pMSC expressed aSMA at protein level.
Therefore, we suggest that in such conditions the majority of cells
develop into myofibroblasts. Incubation of MSC with Huh-7 cells-
conditioned medium containing 5% FCS showed that factors
secreted by Huh-7 cells induce aSMA expression. Compared to
forskin fibroblasts, MSC displayed a higher fibrogenic potential in
cell culture. Whether the increased expression of alpha smooth
muscle actin is related to the tumorgenic nature of Huh-7 cells has
to be determined.
Figure 4. Alpha smooth muscle actin expression in adult and pediatric MSC cultured in various conditions. A) Cell extracts from aMSC
and pMSC cultured with or without Huh-7 cells in hepatogenic differentiation medium during 4 weeks were analyzed for their expression of aSMA
and compared to aMSC cultured in control condition with low FCS concentration (IMDM 2% FCS) by Western blotting. B) Adult MSC and pMSC and
EDX cells where incubated with medium (DMEM 5% FCS) conditioned by Huh-7 cells during 7 days. A and B show representative results of multiple
blots. aSMA: alpha smooth muscle actin; aMSC: adult multipotent mesenchymal stromal cells; pMSC: pediatric multipotent mesenchymal stromal
cells; EDX: human foreskin fibroblasts.
doi:10.1371/journal.pone.0006657.g004
Table 1. Summary of in vivo experiments.
Type of
cells % of hepatectomy Retrorsine
Intrasplenic (S) or
intrahepatic (H) injection
Nb of
mice
Engraftment
spleen Engraftment liver
Differentiation
into hepatocytes
rate dist.
aMSC 30 n S 23 y 0 0 n
aMSC 30 y S 2 y 0 0 n
pMSC 30 n S 25 y 0 0 n
pMSC 70 y S 11 y 0 0 n
pMSC 70 y H 8 na 8/8 6:loc. 2:diff. n
aMSC 70 y H 8 na 8/8 5:loc. 3:diff. n
aMSC: adult multipotent mesenchymal stromal cells; pMSC: pediatric multipotent mesenchymal stromal cells; y: yes; n: no; na: not applicable; dist.: distribution;
loc.: localized; diff.: diffuse.
doi:10.1371/journal.pone.0006657.t001
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albumin Ab did not detect any albumin positive cells within mouse liver parenchyma (a,b,c). Scale bars indicate magnification. B) Total RNA was
extracted from sham injected or transplanted mouse liver. Expression of human vimentin, human aFP and human albumin was analyzed by RT-PCR in
several liver tissues after intra-hepatic transplantation with human MSC. Sham: sham injected mouse liver. C+: positive control for human vimentin
was RT-PCR on MSC extract. Positive control for aFP and albumin was RT-PCR on human hepatocytes extract. C-: negative control without
polymerase. Vimentin was expressed in liver tissue demonstrating engraftment of MSC. Human aFP and albumin were never detected. Each figure
shows one representative result of several independent experiments (see table 1).
doi:10.1371/journal.pone.0006657.g006
Figure 5. Liver engraftment of MSC in a mouse model of liver injury, after intrasplenic or intra-hepatic transplantation. A) When
injected into the spleen of NOD/SCID mice, human adult and pediatric MSC engrafted and survived for 8 weeks in the spleen (a). Only few cells
migrated to the liver with maximum 3 cells per high-power field observed (arrow, b). Anti-human vimentin Ab (panel a,b), Hoechst (panel c,d), overlay
(lower panel e,f). B) When injected into liver parenchyma, MSC engrafted and high numbers of cells were detected (a,b). However, they retained their
spindle shape morphology (b). Anti-human vimentin Ab (panel a,b), Hoechst (panel c,d), overlay (panel e,f). Higher magnification (b,d,f).
doi:10.1371/journal.pone.0006657.g005
Human MSC in Injured Liver
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migrated into the liver and completely disappeared within 7 days
as described by others [34]. Other studies achieved low level of
engraftment and differentiation of MSC into hepatocytes after
intravenous injection or transplantation into portal vein or spleen
[35,36,33]. It appears that limited transmigration through the
endothelial barrier hampers MSC to enter liver parenchyma. In
order to expose MSC directly to liver tissue, we injected cells into
the remaining 30% of liver and observed long-term survival.
However, differentiation of MSC into hepatocytes did not occur as
well. Differentiation of human MSC into hepatocyte-like cells after
direct injection into liver parenchyma has been described in a rat
model of chronic liver injury [37]. Sato and colleagues identified
human albumin and aFP-positive clusters in CCl4-treated and
immunosuppressed rats. Using an allogeneic rat model, Popp and
colleagues reported that MSC do not stably engraft into retrorsine-
treated and partially hepatectomized mice [34]. The discrepancy
of survival and engraftment of MSC in liver might be related to
the immunocompetent model used [34] as clearing of MSC might
be under the control of the immune-system [38].
In our study using immunodeficient recipients, we observed
long-term engraftment of MSC in liver parenchyma. Histology
showed that cells integrated randomly into the tissue without
specific distribution. MSC expressed aSMA, a marker for
myofibroblasts [39] and vascular smooth muscle cells [40]. In
transplanted liver, MSC localization merged with collagen
deposition. Injured liver secretes large amount of growth factors
and cytokines, i.e. tumor necrosis factor alpha (TNFa), interleukin
6 (IL6) and later transforming growth factor beta 1 (TGFb1) [41].
Therefore, increased levels of TGFb may induce migration of
MSC through up regulation of molecules such as CD44 [42] and
differentiation of MSC into myofibroblast [43].
Fibrogenic potential of adult bone marrow-derived MSC was
described in a mouse model of chronic liver injury [36].
Expression of aSMA has also been observed in umbilical cord-
derived MSC in vitro but their fibrogenic effect had not been
confirmed in vivo [14]. Despite beneficial effects of MSC on liver
fibrosis [13,12,11], our data showed that bone-marrow-derived
MSC from adult and pediatric donors, transplanted into
regenerating liver, displayed fibrogenic activity, indicating a
potential harmful effect on liver parenchyma.
In conclusion, in vitro albumin expression was induced
frequently in MSC derived from pediatric donors but could not
be detected at protein level. Further, under such conditions MSC
showed increased fibrogenic potential. In vivo, both aMSC and
pMSC implanted in injured and regenerating liver parenchyma
were not able to differentiate into hepatocytes. In the liver
parenchyma, MSC remained mesenchymal, expressed aSMA and
their localization merged with collagen deposition. These results
indicate that adult as well as pediatric MSC were able to develop
Figure 7. Engrafted MSC express alpha smooth muscle actin and merge with collagen deposition in mouse liver. Eight weeks after
injection, sections from MSC injected (A) or sham injected (B) livers were stained with an Ab specific against human vimentin (panels a) or an Ab
against aSMA (panels b) or with Hoechst (panels e). MSC retained their spindle like morphology and formed band-like structures similar to fibrotic
livers. Overlay images of Hoechst and vimentin (panels c) or Hoechst and aSMA (panels d) are shown. Serial sections were stained with Masson to
visualize collagen deposition (blue staining). Comparing collagen stained by Masson (blue) with staining of vimentin and aSMA demonstrate similar
localization (Aa, Ab, Af).
doi:10.1371/journal.pone.0006657.g007
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fibrogenic potential of MSC is of strong interest since MSC are
currently considered for cell therapy in human.
Materials and Methods
Human bone marrow derived multipotent mesenchymal
stromal cells isolation and culture
Human adult and pediatric bone marrow cells were collected
from femoral heads, condyles, or bone resections of orthopedic adult
and pediatric patients, after written consent from informed patients.
This research project was accepted by local Ethical Committees of
the Departments of Surgery and Pediatrics, University Hospital
Geneva, Switzerland (protocols 01-172/chir01-015 and 04-228/
matped04-008). Cells were isolated from bone fragments and
cultured as previously described. Medium consisted in Iscove’s
modified Dulbecco’s Medium (IMDM) (Cambrex, Verviers, Bel-
gium), 10% fetal calf serum (FCS) (Gibco-Invitrogen, Basel,
Switzerland), 100 IU/ml Penicillin, 100 mg/ml Streptomycin (P–S)
(Gibco-Invitrogen), Dithiothreitol (DTT, Sigma, St-Louis, USA) and
10 ng/ml Platelet Derived Growth Factor BB (PDGF-BB, Pepro-
Tech EC Ltd, London, UK). Cells were expanded as previously
described [5,7] and used for experiments between passages 3 to 6.
Culture of human foreskin fibroblasts, human hepatoma
cells, mouse 3T3 cells, immortalized human hepatocytes
Human foreskin fibroblasts (EDX) (a gift from DFB Bioscience)
and human hepatoma cells (Huh-7) cells (a gift from Benoı ˆt
Gauthier, University of Geneva, Switzerland) were maintained in
expansion medium consisting of Dulbecco’s Modified Eagle
Medium (DMEM) (Low Glucose, Gibco-Invitrogen) with 5% FCS
for EDX cells and10%FCSfor Huh-7cellsrespectively,with P–Sat
37uCa n d5 %C O 2. Huh-7 cell-conditioned medium (DMEM 5%
FCS) was collected every 3 d, filtered and stored at 220uCu n t i lu s e .
Immortalizedhumanhepatocytes(IHH)wereculturedinmediumas
described [44]. Mouse 3T3 cells were cultured in DMEM high
glucose supplemented with 10% FCS and P–S.
Antibodies
Following antibodies (Ab) were used for fluorescent activated cell
sorting (FACS) analysis and immunohistochemistry: mouse anti-
CD11b (Hycultbiotechnology,Uden,theNetherlands),mouseanti-
CD31 (Dako, Baar, Switzerland), phycoerythrin (PE)-conjugated
mouse anti-CD34, Fluorescein isothiocyanate (FITC)-conjugated
mouse anti-CD36, PE-mouse anti-CD44, PE-mouse anti-CD54,
mouse anti-CD90, mouse anti-CD106, mouse isotype control (all
from Becton Dickinson, Basel, Switzerland), PE-mouse anti-CD45
(R&D systems, Abingdon, UK), FITC-mouse anti-CD105 (Serotec,
Oxford, UK), mouse anti-HLA-ABC (Chemicon Australia, Victo-
ria, Australia), mouse anti-vimentin (Dako, Baar, Switzerland),
mouse anti-human serum albumin, mouse anti-beta cytoplasmic
actin (both from Sigma, Buchs, Switzerland), rabbit anti-human
collagen type II (Mono-San, Uden, The Netherlands) and mouse
anti-humanalphasmoothmuscleactinAb[45].SecondaryAbwere
FITC-rat anti-mouse IgG1, PE-rat anti-mouse IgG1 (both from
Becton Dickinson), horseradish peroxidase-conjugated goat anti-
mouse IgG (Jackson Immunoresearch Laboratories, West Grove,
PA), biotinylated mouse anti-rabbit (Dako) and Alexa Fluor 488
(green) goat-anti mouse (Molecular Probes Inc, Eugene, OR).
Fluorescence Activated Cell Sorting (FACS)
MSC were detached using 0.25% trypsin-EDTA (Sigma, Buchs,
Switzerland) for about 30 s and washed twice. Cells were stained
with antibodies (Ab) against CD11b, CD31, CD34, CD36, CD44,
CD45, CD54, CD90, CD105, CD106, HLA ABC, and mouse
isotype control, at saturating concentrations. Cells were washed
with phosphate buffered saline (PBS) containing 0.1% bovine
serum albumin (BSA) and 0.1% azide (all from Sigma, Buchs,
Switzerland) and those labeled with unconjugated Ab were
secondary labeled with FITC or PE secondary rat anti-mouse
Ab, washed and analyzed using a FACScan flow cytometry system
(Becton Dickinson Immunocytometry Systems, Basel, Switzer-
land). Mouse isotype standard immunoglobulin and secondary Ab
alone were used as negative controls. Data were analyzed using
Win MDI program (Scripps, La Jolla, Ca, USA).
Mesodermal differentiation
Adipogenic differentiation: Adult MSC and pMSC were
trypsinized and seeded at high density (209000–259000 cells/
cm
2). MSC were cultured at 37uC in presence of 5% CO2 for 3
weeks on adherent Petri dishes (Falcon, Becton Dickinson, Basel,
Switzerland) in adipogenic differentiation media composed of
IMDM, 10% rabbit serum (Sigma, Buchs, Switzerland), 0.5 mM
3-Isobutyl-1-methylxanthin (IBMX), 1 mM hydrocortisone,
0.1 mM indomethacin (all from Sigma, Buchs, Switzerland) and
P–S. Media were changed every 3 d. Cells were fixed with cold
10% formalin for 1 h, then washed twice with water and stained
with Oil-red-O solution (Sigma, Buchs, Switzerland) for 2 h at
room temperature (RT), to reveal triglyceride droplets in the
cytoplasm. Cells were washed twice, coverslipped and observed
under an optical microscope (Zeiss Axiophot1, Carl Zeiss AG,
Feldbach, Switzerland).
Osteogenic differentiation: Adult MSC and pMSC were
trypsinized and seeded at high density (209000–259000 cells/
cm
2). Then, cells were cultured at 37uC with 5% CO2 up to 3
weeks on adherent Petri dishes in osteogenic differentiation media
based on IMDM, dexamethasone 0.1 mM, b-glycerolphosphate
10 mM, ascorbic acid 200 mM (all from Sigma, Buchs, Switzer-
land), and P–S. Media was changed every 3 d. Cells were fixed in
10% formalin for 1 h and were either stained with von Kossa
staining to detect calcium deposition or stained using alkaline
phosphatase activity test. Briefly, for von Kossa staining, after
fixation cells were rinsed with distilled water and incubated with a
5% Silver Nitrate solution under strong light for 5 min at RT.
After washing with distilled water, coloration was fixed with a 1%
sodium thiosulfate solution for 5 min, washed again and nuclei
were stained with Nuclear Red for 15 min at RT. Cells were
washed twice and observed under an optical microscope (Zeiss
Axiophot1). For alkaline phosphatase staining, fixed cells were
washed twice with PBS and once with Tris/NaCl (50 mM/
150 mM) pH 10 buffer. Cells were then incubated with a mix of 5
vol of a solution of Sodium alpha-naphtyl phosphate (170 mg/ml)
and 1 vol of Fast Red TR solution (1 mg/ml) (both from Sigma)
for 30 min at 4uC. After washing with PBS, nuclei were stained
with Hemalun for 1–2 min at RT and then cells were washed with
water, and observed under an optical microscope (Zeiss Axio-
phot1).
Chondrogenic differentiation: Adult MSC and pMSC were
trypsinized and 3009000 cells were centrifuged at 2006g for 5 min.
The pellet was rinsed with PBS and then cultured in a Falcon tube
for 3 weeks in a chondrogenic differentiation media based on
DMEM – high glucose (25 mmol/l of glucose), 0.1 mM dexameth-
asone, 50 mg/ml ascorbic acid, 10 mg/l insulin, 5.5 mg/l transfer-
rin, 5 mg/l selenium (ITS)-premix, 40 mg/ml L-proline (all from
Sigma, Buchs, Switzerland a), 10 ng/ml TGFb1 or TGFb3 (both
from PeproTech EC Ltd, London, UK), P–S at 37uC in presence of
5% CO2, and media were changed every 3 d. Pellets were fixed
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dehydrated, embedded in paraffin. Chondrogenic differentiation
was then assessed by immunohistochemistry (see paragraph
Immunohistochemistry). 5 mm sections were stained with Masson-
Goldner trichrome and Alcian blue to reveal collagen fibrils and
glycosaminoglycan, respectively. Slides were mounted and observed
under an optical microscope (Zeiss Axiophot 1).
Hepatic differentiation
Two different protocols were used to induce hepatic differen-
tiation. First, aMSC and pMSC were seeded on 1% Matrigel (BD
Biosciences, Allschwil, Switzerland) at a concentration of 209000–
259000 cells/cm
2, and attached for 24 h in expansion medium.
After 24 h, MSC were cultured in hepatogenic differentiation
medium: IMDM, HGF 50 ng/ml, FGF4 50 ng/ml, Oncostatin M
50 ng/ml (all from PeproTech EC, London, England), P–S, DTT
or in control medium: IMDM, 2% FCS, P–S, DTT and 10 ng/ml
PDGF-BB, at 37uC in presence of 5% CO2 for 4 weeks.
Second, aMSC and pMSC were co-cultured with Huh-7 cells in
hepatogenic differentiation medium for four weeks. 2009000 Huh-
7 cells were seeded in a transwell (0.4 mm mesh, Costar, Baar,
Switzerland), and transferred in a 6 well plate (Falcon) in which
aMSC or pMSC were previously plated on 1% Matrigel at a
concentration of 209000–259000 cells/cm
2. Co-Culture in hepa-
togenic medium was compared to the co-culture of MSC and
Huh-7 cells in control medium (media as above) at 37uCi n
presence of 5% CO2.
Reverse-Transcription Polymerase Chain Reaction (RT-
PCR)
MSC were lysed after 4 weeks of hepatic differentiation. RNA
was extracted and RT-PCR was performed as previously
described [5]. Expression of aFP, albumin, CK18, CK19 and
API was analyzed using specific primers (Table 2). B-cytoplasmic
actin expression was used as quality control for reverse
transcription.
Telomerase activity
To measure telomerase activity in aMSC and pMSC, we used
TeloTAGGG Telomerase PCR ELISA plus (Roche Diagnostics,
Mannheim, Germany), according to manufacturer’s instruction.
Briefly, 2009000 cells of different donors of aMSC and pMSC, and
also 2009000 cells of IHH expressing telomerase at high levels as
positive controls, were lysed and supernatants were harvested. Cell
extracts were then either heat inactivated (negative controls) or
used without heat inactivation. Reaction mixture and internal
standard were added to each cell extract and transferred to a
thermal cycler. Elongation and amplification were performed as
described by manufacturer’s protocol. Telomerase activity was
then quantified by the TRAP reaction, using an ELISA kit with a
microplate containing precoated wells, to detect amplification
products and thus telomerase activity. Absorbance of samples was
measured at 450 nm and activity was expressed as relative
telomerase activity, compared to a provided positive control.
Relative telomerase activity was calculated by the following
formula: [((AbsS2AbsS0)/AbsS,IS)/((Abs+ctrl2Abs+ctrl0)/Ab-
s+ctrl,IS)]*100, AbsS=sample absorbance, AbsS0=heat inacti-
vated sample absorbance, IS=internal standard, +ctrl=given
positive control.
Protein electrophoresis and immunoblot analysis
After culture of MSC in hepatogenic conditions or in Huh-7
conditioned medium, cells were scraped and thoroughly lysed in
sample buffer (62.5 mM Tris-HCl pH 6.8, 2% sodium dodecyl
sulfate (SDS), 10% glycerol, 50 mM DTT, 0.01% Bromophenol
Blue). Total cell lysates were run on 7.5% SDS minigels [46] (Bio-
Rad Laboratories, Glattbrugg, Switzerland) and electroblotted
onto PVDF membranes (Millipore, Zug, Switzerland). PVDF
membranes were incubated with mouse anti-aSMA Ab and mouse
anti beta cytoplasmic actin Ab diluted in Tris-buffered saline
(TBS) containing 5% milk, overnight at 4uC. After three washes
with TBS, a second incubation was performed with horseradish
peroxidase-conjugated affinity-purified goat anti-mouse IgG at a
dilution of 1:69000 in TBS, containing 5% milk. Peroxidase
activity was developed using the ECL western blotting system
(Amersham, Rahn AG, Zu ¨rich, Switzerland), according to the
manufacturer’s instructions and blots were scanned (Arcus II;
Agfa, Mortsel, Belgium).
Animals
NOD/SCID mice (Centre Medical Universitaire, Geneva,
Switzerland), 8 to 10 weeks old and 20 to 25 g of body weight
were used for experiments. Animals were maintained in specific
pathogen free housing facilities and experimental protocols were
approved by the ethical committee of the Geneva University
Medical School and by Geneva veterinary authorities. Mice had
ad libitum access to food and water.
Retrorsine treatment and partial hepatectomy in NOD/
SCID mice
In some experiments, mice were treated twice at days 228 and
214 before transplantation with 30 mg/g of body weight of
Table 2. PCR primer sets.
Name Forward Reverse uT( uC) Cycles
Product
Size
Genebank
reference
aFP 59-tgcagccaaagtgaagagggaaga-39 59-catagcgagcagcccaaagaagaa-39 59.6 35 217 NM-001134
Albumin 59-tgctgatgacaggg-39 59-gatgagatgcctgctgacttgcctt-39 60 35 151 NM-000477
API 59-agaccctttgaagtcaaggacaccg-39 59-ccattgctgaagaccttagtgatgc-39 58 35 359 NM-000295.4
b actin 59-cgtgggccgccctaggcaccag-39 59-ttggccttagggttcagggggg-39 60 30 243 NM-001101.3
CK18 59-ctctgggttgaccgtggaggt-39 59-tggtgctctcctcaatctgctg-39 55 35 149 NM-199187
CK19 59-atggccgagcagaaccggaa-39 59-ccatgagccgctggtactcc-39 58 35 327 NM-002276
Vimentin 59-gagaactttgccgttgaagc-39 59-cgtgatgctgagaagtttcg-39 51 35 342 NM-003380
CYP3A4 59-tctcatcccagacttggccat-39 59-gaagacagaataacattctt-39 55 32 300 NM-017460.3
doi:10.1371/journal.pone.0006657.t002
Human MSC in Injured Liver
PLoS ONE | www.plosone.org 9 August 2009 | Volume 4 | Issue 8 | e6657retrorsine (Sigma), an inhibitor of endogenous liver regeneration
[34]. Under general anesthesia, a median laparotomy was
performed and the left lateral liver lobe (30% hepatectomy) or
left lateral, left upper and right anterior lobes (68% hepatectomy)
were ligated and removed as previously described by Greene and
Puder [47].
Transplantation of human MSC into partially
hepatectomized NOD/SCID mice
Mice underwent a second laparotomy under general anesthesia,
48 h post-hepatectomy. For intrasplenic injections, undifferentiated
MSC suspended in 50–100 ml Hanks’ Buffered Saline Solution
(HBSS) were injected with a 25 G butterfly catheter. For
intrahepatic injections, MSC suspended in 50–100 ml HBSS were
injected into two sites of the remaining right lower lobe. Sham
animals were operated as transplanted animals and 100 mlo fH B S S
was injected either into the spleen or the hepatic parenchyma.
Organ retrieval and fixation
After various time points (from 5 min to 8 weeks), mice were
euthanized by exsanguination under general anesthesia and
organs were retrieved. Liver and spleen were dissected and fixed
in 10% formalin. Organs were dehydrated and embedded in
paraffin. Five mm-thick tissue sections were performed at 3
different levels on liver and spleen.
Immunohistochemistry and histochemistry
All paraffin sections were dewaxed, and rehydrated using xylene
and successive ethanol baths.
For detection of mesenchymal cells, hepatic and fibrogenic
markers, mouse anti-vimentin (1:1000), mouse anti-human
albumin (1:250), mouse anti-aSMA (1:500), were used respective-
ly. Before incubation with the specific Ab, tissue sections were
treated with sodium citrate 10 mM at pH 6.0 heated for 10 min at
95uC. For slides incubated with anti-albumin Ab, an additional
treatment with image iTTM FX signal enhancer (Molecular
Probes), to block non specific antigen was performed. Tissue
sections were incubated overnight at 4uC with primary Ab (anti-
human vimentin Ab and anti-aSMA Ab) diluted in PBS
containing 0.1% BSA, anti-human albumin was diluted in PBS
containing 5% FCS). Alexa Fluor (green) 488 goat-anti mouse
secondary Ab (1:1000 in PBS containing 5% goat serum) were
incubated for 30 min at RT. Hoechst staining (1:2000) was
performed on certain sections.
For the assessment of chondrogenic differentiation, sections of
pellets were stained against collagen type II. Sections were treated
with hyaluronidase and chondroitinase (both from Sigma) for
15 min at 37uC. After blocking for 1 h with PBS containing 0.5%
BSA, pellets were incubated with rabbit anti-human collagen type
2 Ab (1:20), overnight, at 4uC. Primary Ab binding was revealed
with biotinylated mouse anti-rabbit Ab (1:250) for 30 min at RT
and then with StreptABcomplex and Alkaline phosphatase (Dako,
Glostrup, Denmark) for 30 min at RT, according to manufactur-
er’s instruction. Incubation with Fast Red for 5–10 min revealed
the antigen. Nuclei were colored by Hemalun.
For histochemistry using Masson’s trichrome [48,49], Slides
were then incubated for 1 h at 60uC in Bouin’s solution as
mordant. Slides were washed in tap water for 5 min. Nuclei were
stained with hematoxylin. Slides were washed with tap water for
5 min. Cytoplasm was stained with Biebrich scarlet for 5 min.
Slides were rinsed in distilled water, incubated in phosphomolyb-
dic acid for 10 min, transferred into Aniline blue for 5 min to stain
collagen and rinsed in distilled water. They were then rinsed in 2%
acetic acid for 1 min, rapidly dehydrated in ethanol 95% and
100%, followed by xylol.
Stained slides were coverslipped and tissue sections were
observed using an Axiophot microscope (Carl Zeiss AG, Feldbach,
Switzerland) and images were acquired with an Axiocam color
camera (Zeiss).
Statistics
Results were analyzed by Student’s. P-values of p#0.05 were
considered statistically significant.
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